nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP1A2—Imiquimod—skin cancer	0.121	0.165	CbGbCtD
Efavirenz—CYP2C19—Vismodegib—skin cancer	0.0909	0.124	CbGbCtD
Efavirenz—CYP2C9—Vismodegib—skin cancer	0.0756	0.103	CbGbCtD
Efavirenz—CYP1A2—Vemurafenib—skin cancer	0.0663	0.0904	CbGbCtD
Efavirenz—CYP3A4—Imiquimod—skin cancer	0.0634	0.0865	CbGbCtD
Efavirenz—CYP3A4—Temozolomide—skin cancer	0.0634	0.0865	CbGbCtD
Efavirenz—CYP2D6—Vemurafenib—skin cancer	0.0547	0.0745	CbGbCtD
Efavirenz—CYP1A2—Dacarbazine—skin cancer	0.0508	0.0693	CbGbCtD
Efavirenz—CYP3A4—Vismodegib—skin cancer	0.044	0.0599	CbGbCtD
Efavirenz—CYP3A4—Vemurafenib—skin cancer	0.0348	0.0474	CbGbCtD
Efavirenz—CYP1A2—Fluorouracil—skin cancer	0.0298	0.0406	CbGbCtD
Efavirenz—CYP2C9—Fluorouracil—skin cancer	0.0269	0.0366	CbGbCtD
Efavirenz—CYP3A4—Docetaxel—skin cancer	0.0119	0.0163	CbGbCtD
Efavirenz—Feeling abnormal—Imiquimod—skin cancer	0.000315	0.00118	CcSEcCtD
Efavirenz—Gastrointestinal pain—Imiquimod—skin cancer	0.000313	0.00117	CcSEcCtD
Efavirenz—Visual impairment—Temozolomide—skin cancer	0.000311	0.00117	CcSEcCtD
Efavirenz—Sinusitis—Fluorouracil—skin cancer	0.000311	0.00117	CcSEcCtD
Efavirenz—Erythema—Dactinomycin—skin cancer	0.00031	0.00117	CcSEcCtD
Efavirenz—Ill-defined disorder—Bleomycin—skin cancer	0.000309	0.00116	CcSEcCtD
Efavirenz—Anaemia—Bleomycin—skin cancer	0.000308	0.00115	CcSEcCtD
Efavirenz—Diarrhoea—Vemurafenib—skin cancer	0.000307	0.00115	CcSEcCtD
Efavirenz—Migraine—Docetaxel—skin cancer	0.000305	0.00115	CcSEcCtD
Efavirenz—Erythema multiforme—Temozolomide—skin cancer	0.000305	0.00114	CcSEcCtD
Efavirenz—Urticaria—Imiquimod—skin cancer	0.000304	0.00114	CcSEcCtD
Efavirenz—Abdominal pain—Imiquimod—skin cancer	0.000302	0.00113	CcSEcCtD
Efavirenz—Body temperature increased—Imiquimod—skin cancer	0.000302	0.00113	CcSEcCtD
Efavirenz—Eye disorder—Temozolomide—skin cancer	0.000301	0.00113	CcSEcCtD
Efavirenz—Tinnitus—Temozolomide—skin cancer	0.000301	0.00113	CcSEcCtD
Efavirenz—Malaise—Bleomycin—skin cancer	0.0003	0.00113	CcSEcCtD
Efavirenz—Flushing—Temozolomide—skin cancer	0.000299	0.00112	CcSEcCtD
Efavirenz—Cardiac disorder—Temozolomide—skin cancer	0.000299	0.00112	CcSEcCtD
Efavirenz—Rhinitis—Fluorouracil—skin cancer	0.000298	0.00112	CcSEcCtD
Efavirenz—Dizziness—Vemurafenib—skin cancer	0.000296	0.00111	CcSEcCtD
Efavirenz—Hypoaesthesia—Fluorouracil—skin cancer	0.000296	0.00111	CcSEcCtD
Efavirenz—Angiopathy—Temozolomide—skin cancer	0.000293	0.0011	CcSEcCtD
Efavirenz—Ataxia—Docetaxel—skin cancer	0.000292	0.00109	CcSEcCtD
Efavirenz—Immune system disorder—Temozolomide—skin cancer	0.000291	0.00109	CcSEcCtD
Efavirenz—Mediastinal disorder—Temozolomide—skin cancer	0.000291	0.00109	CcSEcCtD
Efavirenz—Cough—Bleomycin—skin cancer	0.00029	0.00109	CcSEcCtD
Efavirenz—Ill-defined disorder—Dactinomycin—skin cancer	0.000288	0.00108	CcSEcCtD
Efavirenz—Anaemia—Dactinomycin—skin cancer	0.000287	0.00108	CcSEcCtD
Efavirenz—Vomiting—Vemurafenib—skin cancer	0.000285	0.00107	CcSEcCtD
Efavirenz—Alopecia—Temozolomide—skin cancer	0.000285	0.00107	CcSEcCtD
Efavirenz—Chest pain—Bleomycin—skin cancer	0.000283	0.00106	CcSEcCtD
Efavirenz—Myalgia—Bleomycin—skin cancer	0.000283	0.00106	CcSEcCtD
Efavirenz—Rash—Vemurafenib—skin cancer	0.000283	0.00106	CcSEcCtD
Efavirenz—Dermatitis—Vemurafenib—skin cancer	0.000282	0.00106	CcSEcCtD
Efavirenz—Hypersensitivity—Imiquimod—skin cancer	0.000282	0.00106	CcSEcCtD
Efavirenz—Headache—Vemurafenib—skin cancer	0.000281	0.00105	CcSEcCtD
Efavirenz—Erythema—Temozolomide—skin cancer	0.000281	0.00105	CcSEcCtD
Efavirenz—Malnutrition—Temozolomide—skin cancer	0.000281	0.00105	CcSEcCtD
Efavirenz—Breast disorder—Docetaxel—skin cancer	0.00028	0.00105	CcSEcCtD
Efavirenz—Discomfort—Bleomycin—skin cancer	0.00028	0.00105	CcSEcCtD
Efavirenz—Malaise—Dactinomycin—skin cancer	0.00028	0.00105	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000279	0.00105	CcSEcCtD
Efavirenz—Nasopharyngitis—Docetaxel—skin cancer	0.000277	0.00104	CcSEcCtD
Efavirenz—Dysgeusia—Temozolomide—skin cancer	0.000275	0.00103	CcSEcCtD
Efavirenz—Asthenia—Imiquimod—skin cancer	0.000274	0.00103	CcSEcCtD
Efavirenz—Confusional state—Bleomycin—skin cancer	0.000274	0.00103	CcSEcCtD
Efavirenz—Back pain—Temozolomide—skin cancer	0.000272	0.00102	CcSEcCtD
Efavirenz—Pruritus—Imiquimod—skin cancer	0.000271	0.00102	CcSEcCtD
Efavirenz—Nausea—Vemurafenib—skin cancer	0.000266	0.001	CcSEcCtD
Efavirenz—Thrombocytopenia—Bleomycin—skin cancer	0.000266	0.000999	CcSEcCtD
Efavirenz—Arrhythmia—Fluorouracil—skin cancer	0.000265	0.000997	CcSEcCtD
Efavirenz—Vision blurred—Temozolomide—skin cancer	0.000265	0.000993	CcSEcCtD
Efavirenz—Myalgia—Dactinomycin—skin cancer	0.000264	0.000992	CcSEcCtD
Efavirenz—Tremor—Temozolomide—skin cancer	0.000263	0.000988	CcSEcCtD
Efavirenz—Alopecia—Fluorouracil—skin cancer	0.000263	0.000986	CcSEcCtD
Efavirenz—Diarrhoea—Imiquimod—skin cancer	0.000262	0.000982	CcSEcCtD
Efavirenz—Discomfort—Dactinomycin—skin cancer	0.000261	0.00098	CcSEcCtD
Efavirenz—Ill-defined disorder—Temozolomide—skin cancer	0.00026	0.000978	CcSEcCtD
Efavirenz—Anaemia—Temozolomide—skin cancer	0.000259	0.000974	CcSEcCtD
Efavirenz—Anorexia—Bleomycin—skin cancer	0.000259	0.000972	CcSEcCtD
Efavirenz—Erythema—Fluorouracil—skin cancer	0.000259	0.000971	CcSEcCtD
Efavirenz—Agitation—Temozolomide—skin cancer	0.000258	0.000969	CcSEcCtD
Efavirenz—Angioedema—Temozolomide—skin cancer	0.000257	0.000963	CcSEcCtD
Efavirenz—Pancytopenia—Docetaxel—skin cancer	0.000254	0.000955	CcSEcCtD
Efavirenz—Malaise—Temozolomide—skin cancer	0.000253	0.000951	CcSEcCtD
Efavirenz—Dizziness—Imiquimod—skin cancer	0.000253	0.000949	CcSEcCtD
Efavirenz—Vertigo—Temozolomide—skin cancer	0.000252	0.000947	CcSEcCtD
Efavirenz—Palpitations—Temozolomide—skin cancer	0.000248	0.000931	CcSEcCtD
Efavirenz—Thrombocytopenia—Dactinomycin—skin cancer	0.000248	0.000931	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000247	0.000929	CcSEcCtD
Efavirenz—Cough—Temozolomide—skin cancer	0.000245	0.00092	CcSEcCtD
Efavirenz—Paraesthesia—Bleomycin—skin cancer	0.000244	0.000916	CcSEcCtD
Efavirenz—Vision blurred—Fluorouracil—skin cancer	0.000244	0.000915	CcSEcCtD
Efavirenz—Convulsion—Temozolomide—skin cancer	0.000243	0.000913	CcSEcCtD
Efavirenz—Vomiting—Imiquimod—skin cancer	0.000243	0.000913	CcSEcCtD
Efavirenz—Hypertension—Temozolomide—skin cancer	0.000242	0.00091	CcSEcCtD
Efavirenz—Dyspnoea—Bleomycin—skin cancer	0.000242	0.000909	CcSEcCtD
Efavirenz—Anorexia—Dactinomycin—skin cancer	0.000241	0.000907	CcSEcCtD
Efavirenz—Rash—Imiquimod—skin cancer	0.000241	0.000905	CcSEcCtD
Efavirenz—Dermatitis—Imiquimod—skin cancer	0.000241	0.000904	CcSEcCtD
Efavirenz—Pneumonia—Docetaxel—skin cancer	0.00024	0.000902	CcSEcCtD
Efavirenz—Headache—Imiquimod—skin cancer	0.00024	0.000899	CcSEcCtD
Efavirenz—Anaemia—Fluorouracil—skin cancer	0.000239	0.000898	CcSEcCtD
Efavirenz—Arthralgia—Temozolomide—skin cancer	0.000239	0.000897	CcSEcCtD
Efavirenz—Myalgia—Temozolomide—skin cancer	0.000239	0.000897	CcSEcCtD
Efavirenz—Infestation NOS—Docetaxel—skin cancer	0.000239	0.000897	CcSEcCtD
Efavirenz—Infestation—Docetaxel—skin cancer	0.000239	0.000897	CcSEcCtD
Efavirenz—Anxiety—Temozolomide—skin cancer	0.000238	0.000894	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000237	0.000891	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000237	0.000889	CcSEcCtD
Efavirenz—Discomfort—Temozolomide—skin cancer	0.000236	0.000887	CcSEcCtD
Efavirenz—Decreased appetite—Bleomycin—skin cancer	0.000236	0.000887	CcSEcCtD
Efavirenz—Renal failure—Docetaxel—skin cancer	0.000235	0.000882	CcSEcCtD
Efavirenz—Neuropathy peripheral—Docetaxel—skin cancer	0.000234	0.000879	CcSEcCtD
Efavirenz—Dry mouth—Temozolomide—skin cancer	0.000234	0.000878	CcSEcCtD
Efavirenz—Jaundice—Docetaxel—skin cancer	0.000233	0.000874	CcSEcCtD
Efavirenz—Pain—Bleomycin—skin cancer	0.000232	0.000872	CcSEcCtD
Efavirenz—Confusional state—Temozolomide—skin cancer	0.000231	0.000867	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000231	0.000867	CcSEcCtD
Efavirenz—Nausea—Imiquimod—skin cancer	0.000227	0.000853	CcSEcCtD
Efavirenz—Hepatobiliary disease—Docetaxel—skin cancer	0.000226	0.000848	CcSEcCtD
Efavirenz—Nervous system disorder—Temozolomide—skin cancer	0.000225	0.000844	CcSEcCtD
Efavirenz—Thrombocytopenia—Temozolomide—skin cancer	0.000224	0.000842	CcSEcCtD
Efavirenz—Convulsion—Fluorouracil—skin cancer	0.000224	0.000841	CcSEcCtD
Efavirenz—Feeling abnormal—Bleomycin—skin cancer	0.000224	0.00084	CcSEcCtD
Efavirenz—Skin disorder—Temozolomide—skin cancer	0.000223	0.000836	CcSEcCtD
Efavirenz—Hyperhidrosis—Temozolomide—skin cancer	0.000222	0.000832	CcSEcCtD
Efavirenz—Chest pain—Fluorouracil—skin cancer	0.00022	0.000827	CcSEcCtD
Efavirenz—Myalgia—Fluorouracil—skin cancer	0.00022	0.000827	CcSEcCtD
Efavirenz—Decreased appetite—Dactinomycin—skin cancer	0.00022	0.000827	CcSEcCtD
Efavirenz—Fatigue—Dactinomycin—skin cancer	0.000218	0.00082	CcSEcCtD
Efavirenz—Anorexia—Temozolomide—skin cancer	0.000218	0.00082	CcSEcCtD
Efavirenz—Discomfort—Fluorouracil—skin cancer	0.000218	0.000817	CcSEcCtD
Efavirenz—Pain—Dactinomycin—skin cancer	0.000217	0.000813	CcSEcCtD
Efavirenz—Urticaria—Bleomycin—skin cancer	0.000216	0.00081	CcSEcCtD
Efavirenz—Rhinitis—Docetaxel—skin cancer	0.000215	0.000807	CcSEcCtD
Efavirenz—Body temperature increased—Bleomycin—skin cancer	0.000215	0.000806	CcSEcCtD
Efavirenz—Hepatitis—Docetaxel—skin cancer	0.000214	0.000805	CcSEcCtD
Efavirenz—Hypoaesthesia—Docetaxel—skin cancer	0.000213	0.000801	CcSEcCtD
Efavirenz—Confusional state—Fluorouracil—skin cancer	0.000213	0.000799	CcSEcCtD
Efavirenz—Urinary tract disorder—Docetaxel—skin cancer	0.000212	0.000795	CcSEcCtD
Efavirenz—Oedema peripheral—Docetaxel—skin cancer	0.000211	0.000793	CcSEcCtD
Efavirenz—Connective tissue disorder—Docetaxel—skin cancer	0.000211	0.000791	CcSEcCtD
Efavirenz—Urethral disorder—Docetaxel—skin cancer	0.00021	0.000789	CcSEcCtD
Efavirenz—Feeling abnormal—Dactinomycin—skin cancer	0.000209	0.000784	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000209	0.000784	CcSEcCtD
Efavirenz—Insomnia—Temozolomide—skin cancer	0.000207	0.000778	CcSEcCtD
Efavirenz—Gastrointestinal pain—Dactinomycin—skin cancer	0.000207	0.000778	CcSEcCtD
Efavirenz—Nervous system disorder—Fluorouracil—skin cancer	0.000207	0.000777	CcSEcCtD
Efavirenz—Thrombocytopenia—Fluorouracil—skin cancer	0.000207	0.000776	CcSEcCtD
Efavirenz—Visual impairment—Docetaxel—skin cancer	0.000207	0.000776	CcSEcCtD
Efavirenz—Tachycardia—Fluorouracil—skin cancer	0.000206	0.000774	CcSEcCtD
Efavirenz—Paraesthesia—Temozolomide—skin cancer	0.000206	0.000772	CcSEcCtD
Efavirenz—Dyspnoea—Temozolomide—skin cancer	0.000204	0.000767	CcSEcCtD
Efavirenz—Somnolence—Temozolomide—skin cancer	0.000204	0.000765	CcSEcCtD
Efavirenz—Erythema multiforme—Docetaxel—skin cancer	0.000203	0.000761	CcSEcCtD
Efavirenz—Dyspepsia—Temozolomide—skin cancer	0.000202	0.000757	CcSEcCtD
Efavirenz—Anorexia—Fluorouracil—skin cancer	0.000201	0.000756	CcSEcCtD
Efavirenz—Eye disorder—Docetaxel—skin cancer	0.0002	0.000753	CcSEcCtD
Efavirenz—Abdominal pain—Dactinomycin—skin cancer	0.0002	0.000752	CcSEcCtD
Efavirenz—Body temperature increased—Dactinomycin—skin cancer	0.0002	0.000752	CcSEcCtD
Efavirenz—Hypersensitivity—Bleomycin—skin cancer	0.0002	0.000751	CcSEcCtD
Efavirenz—Decreased appetite—Temozolomide—skin cancer	0.000199	0.000748	CcSEcCtD
Efavirenz—Flushing—Docetaxel—skin cancer	0.000199	0.000747	CcSEcCtD
Efavirenz—Cardiac disorder—Docetaxel—skin cancer	0.000199	0.000747	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Temozolomide—skin cancer	0.000198	0.000743	CcSEcCtD
Efavirenz—Fatigue—Temozolomide—skin cancer	0.000198	0.000742	CcSEcCtD
Efavirenz—Pain—Temozolomide—skin cancer	0.000196	0.000736	CcSEcCtD
Efavirenz—Constipation—Temozolomide—skin cancer	0.000196	0.000736	CcSEcCtD
Efavirenz—Asthenia—Bleomycin—skin cancer	0.000195	0.000732	CcSEcCtD
Efavirenz—Angiopathy—Docetaxel—skin cancer	0.000195	0.000731	CcSEcCtD
Efavirenz—Immune system disorder—Docetaxel—skin cancer	0.000194	0.000727	CcSEcCtD
Efavirenz—Mediastinal disorder—Docetaxel—skin cancer	0.000193	0.000726	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000192	0.000722	CcSEcCtD
Efavirenz—Pruritus—Bleomycin—skin cancer	0.000192	0.000722	CcSEcCtD
Efavirenz—Arrhythmia—Docetaxel—skin cancer	0.000192	0.000719	CcSEcCtD
Efavirenz—Insomnia—Fluorouracil—skin cancer	0.000191	0.000717	CcSEcCtD
Efavirenz—Paraesthesia—Fluorouracil—skin cancer	0.00019	0.000712	CcSEcCtD
Efavirenz—Alopecia—Docetaxel—skin cancer	0.00019	0.000712	CcSEcCtD
Efavirenz—Feeling abnormal—Temozolomide—skin cancer	0.000189	0.000709	CcSEcCtD
Efavirenz—Dyspnoea—Fluorouracil—skin cancer	0.000188	0.000707	CcSEcCtD
Efavirenz—Somnolence—Fluorouracil—skin cancer	0.000188	0.000705	CcSEcCtD
Efavirenz—Gastrointestinal pain—Temozolomide—skin cancer	0.000187	0.000703	CcSEcCtD
Efavirenz—Erythema—Docetaxel—skin cancer	0.000187	0.000701	CcSEcCtD
Efavirenz—Malnutrition—Docetaxel—skin cancer	0.000187	0.000701	CcSEcCtD
Efavirenz—Hypersensitivity—Dactinomycin—skin cancer	0.000187	0.000701	CcSEcCtD
Efavirenz—Dyspepsia—Fluorouracil—skin cancer	0.000186	0.000698	CcSEcCtD
Efavirenz—Decreased appetite—Fluorouracil—skin cancer	0.000184	0.000689	CcSEcCtD
Efavirenz—Dysgeusia—Docetaxel—skin cancer	0.000183	0.000686	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000182	0.000684	CcSEcCtD
Efavirenz—Urticaria—Temozolomide—skin cancer	0.000182	0.000683	CcSEcCtD
Efavirenz—Asthenia—Dactinomycin—skin cancer	0.000182	0.000682	CcSEcCtD
Efavirenz—Abdominal pain—Temozolomide—skin cancer	0.000181	0.00068	CcSEcCtD
Efavirenz—Body temperature increased—Temozolomide—skin cancer	0.000181	0.00068	CcSEcCtD
Efavirenz—Back pain—Docetaxel—skin cancer	0.000181	0.000678	CcSEcCtD
Efavirenz—Pain—Fluorouracil—skin cancer	0.000181	0.000678	CcSEcCtD
Efavirenz—Feeling abnormal—Fluorouracil—skin cancer	0.000174	0.000653	CcSEcCtD
Efavirenz—Diarrhoea—Dactinomycin—skin cancer	0.000173	0.000651	CcSEcCtD
Efavirenz—Vomiting—Bleomycin—skin cancer	0.000173	0.000648	CcSEcCtD
Efavirenz—Anaemia—Docetaxel—skin cancer	0.000173	0.000648	CcSEcCtD
Efavirenz—Rash—Bleomycin—skin cancer	0.000171	0.000643	CcSEcCtD
Efavirenz—Dermatitis—Bleomycin—skin cancer	0.000171	0.000642	CcSEcCtD
Efavirenz—Hypersensitivity—Temozolomide—skin cancer	0.000169	0.000634	CcSEcCtD
Efavirenz—Urticaria—Fluorouracil—skin cancer	0.000168	0.00063	CcSEcCtD
Efavirenz—Syncope—Docetaxel—skin cancer	0.000167	0.000629	CcSEcCtD
Efavirenz—Body temperature increased—Fluorouracil—skin cancer	0.000167	0.000627	CcSEcCtD
Efavirenz—Palpitations—Docetaxel—skin cancer	0.000165	0.000619	CcSEcCtD
Efavirenz—Asthenia—Temozolomide—skin cancer	0.000164	0.000617	CcSEcCtD
Efavirenz—Loss of consciousness—Docetaxel—skin cancer	0.000164	0.000616	CcSEcCtD
Efavirenz—Cough—Docetaxel—skin cancer	0.000163	0.000612	CcSEcCtD
Efavirenz—Pruritus—Temozolomide—skin cancer	0.000162	0.000609	CcSEcCtD
Efavirenz—Convulsion—Docetaxel—skin cancer	0.000162	0.000607	CcSEcCtD
Efavirenz—Nausea—Bleomycin—skin cancer	0.000161	0.000606	CcSEcCtD
Efavirenz—Hypertension—Docetaxel—skin cancer	0.000161	0.000605	CcSEcCtD
Efavirenz—Vomiting—Dactinomycin—skin cancer	0.000161	0.000605	CcSEcCtD
Efavirenz—Rash—Dactinomycin—skin cancer	0.00016	0.0006	CcSEcCtD
Efavirenz—Myalgia—Docetaxel—skin cancer	0.000159	0.000597	CcSEcCtD
Efavirenz—Arthralgia—Docetaxel—skin cancer	0.000159	0.000597	CcSEcCtD
Efavirenz—Chest pain—Docetaxel—skin cancer	0.000159	0.000597	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000158	0.000593	CcSEcCtD
Efavirenz—Diarrhoea—Temozolomide—skin cancer	0.000157	0.000589	CcSEcCtD
Efavirenz—Hypersensitivity—Fluorouracil—skin cancer	0.000156	0.000584	CcSEcCtD
Efavirenz—Dry mouth—Docetaxel—skin cancer	0.000155	0.000584	CcSEcCtD
Efavirenz—Confusional state—Docetaxel—skin cancer	0.000154	0.000577	CcSEcCtD
Efavirenz—Dizziness—Temozolomide—skin cancer	0.000152	0.000569	CcSEcCtD
Efavirenz—Nausea—Dactinomycin—skin cancer	0.00015	0.000565	CcSEcCtD
Efavirenz—Shock—Docetaxel—skin cancer	0.00015	0.000563	CcSEcCtD
Efavirenz—Nervous system disorder—Docetaxel—skin cancer	0.000149	0.000561	CcSEcCtD
Efavirenz—Pruritus—Fluorouracil—skin cancer	0.000149	0.000561	CcSEcCtD
Efavirenz—Thrombocytopenia—Docetaxel—skin cancer	0.000149	0.00056	CcSEcCtD
Efavirenz—Tachycardia—Docetaxel—skin cancer	0.000149	0.000558	CcSEcCtD
Efavirenz—Skin disorder—Docetaxel—skin cancer	0.000148	0.000556	CcSEcCtD
Efavirenz—Vomiting—Temozolomide—skin cancer	0.000146	0.000547	CcSEcCtD
Efavirenz—Anorexia—Docetaxel—skin cancer	0.000145	0.000545	CcSEcCtD
Efavirenz—Rash—Temozolomide—skin cancer	0.000144	0.000542	CcSEcCtD
Efavirenz—Diarrhoea—Fluorouracil—skin cancer	0.000144	0.000542	CcSEcCtD
Efavirenz—Dermatitis—Temozolomide—skin cancer	0.000144	0.000542	CcSEcCtD
Efavirenz—Headache—Temozolomide—skin cancer	0.000144	0.000539	CcSEcCtD
Efavirenz—Dizziness—Fluorouracil—skin cancer	0.00014	0.000524	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000139	0.000521	CcSEcCtD
Efavirenz—Insomnia—Docetaxel—skin cancer	0.000138	0.000517	CcSEcCtD
Efavirenz—Paraesthesia—Docetaxel—skin cancer	0.000137	0.000514	CcSEcCtD
Efavirenz—Nausea—Temozolomide—skin cancer	0.000136	0.000511	CcSEcCtD
Efavirenz—Dyspnoea—Docetaxel—skin cancer	0.000136	0.00051	CcSEcCtD
Efavirenz—Somnolence—Docetaxel—skin cancer	0.000135	0.000509	CcSEcCtD
Efavirenz—Vomiting—Fluorouracil—skin cancer	0.000134	0.000504	CcSEcCtD
Efavirenz—Dyspepsia—Docetaxel—skin cancer	0.000134	0.000504	CcSEcCtD
Efavirenz—Rash—Fluorouracil—skin cancer	0.000133	0.0005	CcSEcCtD
Efavirenz—Dermatitis—Fluorouracil—skin cancer	0.000133	0.000499	CcSEcCtD
Efavirenz—Decreased appetite—Docetaxel—skin cancer	0.000132	0.000497	CcSEcCtD
Efavirenz—Headache—Fluorouracil—skin cancer	0.000132	0.000497	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Docetaxel—skin cancer	0.000132	0.000494	CcSEcCtD
Efavirenz—Fatigue—Docetaxel—skin cancer	0.000131	0.000493	CcSEcCtD
Efavirenz—Constipation—Docetaxel—skin cancer	0.00013	0.000489	CcSEcCtD
Efavirenz—Pain—Docetaxel—skin cancer	0.00013	0.000489	CcSEcCtD
Efavirenz—Feeling abnormal—Docetaxel—skin cancer	0.000126	0.000471	CcSEcCtD
Efavirenz—Nausea—Fluorouracil—skin cancer	0.000125	0.000471	CcSEcCtD
Efavirenz—Gastrointestinal pain—Docetaxel—skin cancer	0.000125	0.000468	CcSEcCtD
Efavirenz—Abdominal pain—Docetaxel—skin cancer	0.00012	0.000452	CcSEcCtD
Efavirenz—Body temperature increased—Docetaxel—skin cancer	0.00012	0.000452	CcSEcCtD
Efavirenz—Hypersensitivity—Docetaxel—skin cancer	0.000112	0.000421	CcSEcCtD
Efavirenz—Asthenia—Docetaxel—skin cancer	0.000109	0.00041	CcSEcCtD
Efavirenz—Pruritus—Docetaxel—skin cancer	0.000108	0.000405	CcSEcCtD
Efavirenz—Diarrhoea—Docetaxel—skin cancer	0.000104	0.000391	CcSEcCtD
Efavirenz—Dizziness—Docetaxel—skin cancer	0.000101	0.000378	CcSEcCtD
Efavirenz—Vomiting—Docetaxel—skin cancer	9.69e-05	0.000364	CcSEcCtD
Efavirenz—Rash—Docetaxel—skin cancer	9.61e-05	0.000361	CcSEcCtD
Efavirenz—Dermatitis—Docetaxel—skin cancer	9.6e-05	0.00036	CcSEcCtD
Efavirenz—Headache—Docetaxel—skin cancer	9.55e-05	0.000358	CcSEcCtD
Efavirenz—Nausea—Docetaxel—skin cancer	9.05e-05	0.00034	CcSEcCtD
